Roux-en-Y Gastric Bypass Is an Effective Bridge to Kidney Transplantation: Results from a Single Center

• Many patients with severe obesity and kidney failure cannot receive a transplant until they lose enough weight to meet BMI requirements. This study showed gastric bypass can safely help patients qualify for transplant.
• Patients successfully lost weight, qualified for transplant listing, and went on to receive kidney transplants with successful outcomes.
• Dr. de la Cruz-Muñoz performed the bariatric procedures, collaborating with the University of Miami's kidney transplant team.
• This study is part of a broader body of work demonstrating expertise in bariatric surgery for patients with advanced kidney disease, including a companion study on peritoneal dialysis patients.
• The concept of bariatric surgery as a bridge to transplant has gained significant traction, with 2023 ASMBS/IFSO Guidelines now addressing this pathway.
• For patients told they are too heavy for a kidney transplant, this study offers hope through bariatric surgery.

Why This Study Was Needed

Obesity is common among people with end-stage kidney disease, and many transplant centers will not list a patient whose BMI is above 35 to 40 because of higher surgical and graft risks. For these patients, losing weight is the gateway to a new kidney, yet dieting while on dialysis is very difficult. Bariatric surgery offers a path, but there was little data on how transplant outcomes compare after gastric bypass.

How the Study Was Done

This single-center study from the University of Miami transplant and bariatric programs reviewed 31 patients with chronic kidney disease on dialysis who had laparoscopic Roux-en-Y gastric bypass between 2009 and 2014 to qualify for transplant. Fourteen went on to receive a kidney. They were compared with 19 historical transplant recipients with a BMI of 36 or more who did not have bypass. Most patients in both groups were Black or Hispanic, and most had long-standing diabetes.

What the Study Found

• Average BMI before bypass was 43.5, and 87% of patients (27 of 31) reached a BMI below 35, the typical threshold for transplant listing.
• 29% had better control of diabetes or high blood pressure.
• 26% had complications after bypass, mostly minor.
• After transplant, biopsy-proven acute rejection was more frequent in bypass patients (6 of 14 vs 3 of 19).
• Rejection was strongly linked to low tacrolimus levels (below 4.0 ng/mL); once this was accounted for, bypass itself was no longer a significant factor.
• Infections, graft survival and patient survival were not significantly different between groups.

What This Means for Patients

For a patient whose weight is the only barrier to a kidney transplant, gastric bypass can open that door. The study also identified an important lesson: bypass changes how anti-rejection medications are absorbed, so transplant teams must monitor drug levels closely and adjust doses. Patients considering this path should be cared for by a bariatric surgeon who works closely with their transplant center. Today, sleeve gastrectomy is often favored before transplant partly because it affects medication absorption less. Start with Am I a Candidate?.

Clinical Pearls

• 87% of dialysis patients reached a transplant-eligible BMI after gastric bypass.
• Higher rejection after bypass was explained by low tacrolimus trough levels.
• Close monitoring of immunosuppressant levels is essential after bypass.
• Graft and patient survival were similar to heavier controls without bypass.

Strengths and Limitations

This is a real-world experience from a high-volume academic transplant center serving a predominantly Black and Hispanic population. The number of patients is small, controls were historical rather than concurrent, and follow-up after transplant was limited, so the findings are hypothesis-generating.

Expert Commentary

Patients on dialysis who are told they are too heavy for a transplant are in a very difficult situation. This collaboration with our transplant colleagues showed that bariatric surgery can get the vast majority of them to a listable weight. It also taught us that after bypass, anti-rejection drug levels must be watched more closely. Weight loss surgery and transplant care have to be planned together.

— Dr. Nestor de la Cruz-Muñoz